ID   DT-6I
AC   CVCL_YQ04
SY   DT6I
DR   Wikidata; Q93532057
RX   PubMed=23992230;
RX   PubMed=24013424;
RX   PubMed=25015330;
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 4
//
RX   PubMed=23992230; DOI=10.1111/ejh.12192; PMCID=PMC3834223;
RA   Greenberg A.J., Walters D.K., Kumar S.K., Rajkumar S.V., Jelinek D.F.;
RT   "Responsiveness of cytogenetically discrete human myeloma cell lines
RT   to lenalidomide: lack of correlation with cereblon and interferon
RT   regulatory factor 4 expression levels.";
RL   Eur. J. Haematol. 91:504-513(2013).
//
RX   PubMed=24013424; DOI=10.4161/cc.26193; PMCID=PMC3865013;
RA   Walters D.K., Arendt B.K., Jelinek D.F.;
RT   "CD147 regulates the expression of MCT1 and lactate export in multiple
RT   myeloma cells.";
RL   Cell Cycle 12:3175-3183(2013).
//
RX   PubMed=25015330; DOI=10.18632/oncotarget.2159; PMCID=PMC4170605;
RA   Arendt B.K., Walters D.K., Wu X., Tschumper R.C., Jelinek D.F.;
RT   "Multiple myeloma cell-derived microvesicles are enriched in CD147
RT   expression and enhance tumor cell proliferation.";
RL   Oncotarget 5:5686-5699(2014).
//